Atlis stockholders approve reorganization merger and Nxu 2023 Omnibus Incentive Plan

Nxu, Inc.

Stockholders approved the Holding Company Proposal for Atlis to be replaced by Nxu as the public company.
Nxu, Inc. 2023 Omnibus Incentive Plan authorizes up to 350 million shares of common stock.
Holding Company Proposal passed: 333,041,464 for, 438,270 against, 69,721 abstain.
Incentive Plan passed: 332,594,715 for, 734,051 against, 220,689 abstain.

item 5.02 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nxu, Inc. shareholders approved Adopt and approve the Nxu, Inc. 2023 Omnibus Incentive Plan at the 2023-05-09 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-05-09

Exact text from the filing

2. A proposal to adopt and approve the Nxu, Inc. 2023 Omnibus Incentive Plan was approved by the following vote: Votes for 332,594,715 Votes against 734,051 Abstained 220,689 Broker non-votes 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nxu, Inc. shareholders approved Adopt and approve the Agreement and Plan of Merger by and among Atlis, Nxu and Atlis Merger Sub, Inc. (the "Holding Company Proposal") at the 2023-05-09 meeting.

Proposal: merger approval
Outcome: passed
Meeting: 2023-05-09

Exact text from the filing

1. A proposal to adopt and approve the Agreement and Plan of Merger by and among Atlis, Nxu and Atlis Merger Sub, Inc. (the “Holding Company Proposal”) was approved by the following vote: Votes for 333,041,464 Votes against 438,270 Abstained 69,721 Broker non-votes 0

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Nxu, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-23-006739

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.